ÂÜÀòÂÒÂ×

Gilbert Wong, M.D. has extensive experience in the field of clinical research and development, particularly in the oncology field. Gilbert began their career as an Assistant Professor at Mayo Clinic School of Medicine in 1995 and also worked as a Consultant Physician at Mayo Clinic and Foundation from 1996 to 2005.

In 2005, Dr. Wong transitioned to the pharmaceutical industry and joined Johnson & Johnson as an Associate Director/Director of Clinical Development. Gilbert then worked as the Director/Senior Director of Clinical Research at Anesiva, Inc. from 2007 to 2008. Following this, they served as the Senior Director of Clinical R&D at Impax Pharmaceuticals from 2008 to 2010.

Dr. Wong joined Pfizer, Inc. in 2010 as the Executive Director of Early Oncology Development and Clinical Research, where they worked until 2020. During their time at Pfizer, they played a crucial role in the early development of oncology treatments.

Most recently, Dr. Wong joined BeiGene in 2020 as the Vice President and Head of Early Clinical Development - Immuno-Oncology. In this role, they are responsible for leading the early clinical development efforts in the field of immuno-oncology.

Overall, Dr. Gilbert Wong's work experience showcases their expertise in early clinical development, immuno-oncology, and their contributions to the advancement of oncology treatments.

Gilbert Wong, M.D. has a strong educational background. Gilbert earned their Bachelor of Science and Bachelor of Arts degrees in Biochemistry and Psychology from the University of California, Davis from 1981 to 1986. Gilbert then attended Loyola University Chicago Stritch School of Medicine, where they obtained their Doctor of Medicine (M.D.) degree from 1986 to 1990. Following this, they completed an Anesthesiology Residency at Mayo Clinic Alix School of Medicine from 1990 to 1994. In pursuit of further specialization, they engaged in a Pain Medicine Fellowship at Mayo Clinic from 1994 to 1995 and an NIH Research Training Grant Fellowship in 1995 to 1996.